Background and Aims Hepatitis C virus (HCV) incidence among HIV-positive men who have sex with men (MSM) has increased since 2000, though regional differences have been documented in recent years. We aimed to 1) estimate trends in HCV incidence among HIV-positive MSM, 2) assess the association between incidence and geographical region, age and HIV-related measurements and, 3) assess temporal changes in time from HIV seroconversion to HCV infection. Methods We used data from MSM with well-estimated dates of HIV seroconversion from the CASCADE Collaboration (1990-2014). We allowed for smoothly varying trends in HCV incidence over calendar time using restricted cubic splines. We assessed the association of calendar year, age, CD4 count (lagged...
Scale-up of direct-acting antiviral therapy is expected to abate hepatitis C virus (HCV) incidence a...
BACKGROUND: Internationally, there is a growing recognition that hepatitis C virus (HCV) may be sexu...
Background: Direct acting antivirals (DAA) cure 95% of patients infected with hepatitis C (HCV). Mod...
Background and Aims Hepatitis C virus (HCV) incidence among HIV-positive men who have sex with men (...
BACKGROUND AND AIMS Hepatitis C virus (HCV) incidence among HIV-positive men who have sex with me...
Background. Prospective characterization of hepatitis C virus (HCV) transmission in both human immun...
Background. Hepatitis C virus (HCV) infection has a growing impact on morbidity and mortality in pat...
Background. The hepatitis C virus (HCV) epidemic is evolving rapidly in patients infected with human...
Background. The hepatitis C virus (HCV) epidemic is evolving rapidly in patients infected with huma...
Background. The hepatitis C virus (HCV) epidemic is evolving rapidly in patients infected with human...
International audienceBackground Despite the availability of highly effective direct-acting antivira...
Background. Direct-acting antivirals (DAAa) cure hepatitis C virus (HCV) infections in 95% of infect...
BackgroundLittle is known about the hepatitis C virus (HCV) epidemic among HIV-infected men who have...
Injecting drug users (DU) are at high risk for hepatitis C virus (HCV) and HIV infections. To examin...
Background and Aims: In the last decade, several outbreaks of sexually acquired acute hepatitis C (H...
Scale-up of direct-acting antiviral therapy is expected to abate hepatitis C virus (HCV) incidence a...
BACKGROUND: Internationally, there is a growing recognition that hepatitis C virus (HCV) may be sexu...
Background: Direct acting antivirals (DAA) cure 95% of patients infected with hepatitis C (HCV). Mod...
Background and Aims Hepatitis C virus (HCV) incidence among HIV-positive men who have sex with men (...
BACKGROUND AND AIMS Hepatitis C virus (HCV) incidence among HIV-positive men who have sex with me...
Background. Prospective characterization of hepatitis C virus (HCV) transmission in both human immun...
Background. Hepatitis C virus (HCV) infection has a growing impact on morbidity and mortality in pat...
Background. The hepatitis C virus (HCV) epidemic is evolving rapidly in patients infected with human...
Background. The hepatitis C virus (HCV) epidemic is evolving rapidly in patients infected with huma...
Background. The hepatitis C virus (HCV) epidemic is evolving rapidly in patients infected with human...
International audienceBackground Despite the availability of highly effective direct-acting antivira...
Background. Direct-acting antivirals (DAAa) cure hepatitis C virus (HCV) infections in 95% of infect...
BackgroundLittle is known about the hepatitis C virus (HCV) epidemic among HIV-infected men who have...
Injecting drug users (DU) are at high risk for hepatitis C virus (HCV) and HIV infections. To examin...
Background and Aims: In the last decade, several outbreaks of sexually acquired acute hepatitis C (H...
Scale-up of direct-acting antiviral therapy is expected to abate hepatitis C virus (HCV) incidence a...
BACKGROUND: Internationally, there is a growing recognition that hepatitis C virus (HCV) may be sexu...
Background: Direct acting antivirals (DAA) cure 95% of patients infected with hepatitis C (HCV). Mod...